The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.
Related Posts
The Markets Cheer Trump’s Treasury Pick, Scott Bessent
Investors seemed to signal their approval for Scott Bessent as a safe choice to implement the president-elect’s economic agenda.
How Trump’s Tariffs Could Affect American Companies
Business owners told The Times that President Trump’s tariffs could lead to higher costs and expressed frustration at the sudden uncertainty about policy.
How Roger Goodell Made the NFL the World’s Wealthiest Sports League
Under the expansionist leadership of its commissioner, the National Football League is growing richer and richer. So, too, is Mr. Goodell.